Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. GWP.L Share Price
  4. GWP.L Share Regulatory News
  5. Additional Listing

Pin to quick picksGWP.L Regulatory News (GWP)

GWP.L Information
  • There is currently no data for GWP

Additional Listing

12 Feb 2014 13:47

RNS Number : 9180Z
GW Pharmaceuticals PLC
12 February 2014
 



 

GW Pharmaceuticals PLC

EXERCISE OF WARRANTS

Porton Down, UK, 12 February 2014: GW Pharmaceuticals (AIM: GWP Nasdaq: GWPH) hereby provides notification that application has today been made to the London Stock Exchange for admission to trading on AIM of 1,888,480 new ordinary shares of 0.1p each.

These new ordinary shares are being issued pursuant to the exercise of warrants held by funds managed by Great Point Partners. These warrants represent the remaining 50% of the warrants issued to Great Point Partners in August 2009 which were due to expire in August 2014.

On exercise the new ordinary shares will be issued credited as fully paid and will rank pari passu with the existing ordinary shares in issue.

It is expected that admission will become effective on 19 February 2014.

Enquiries:

GW Pharmaceuticals PLC Tel: +44 (0)1980 557 000

Adam George, Company Secretary

Peel Hunt LLP (Nominated Adviser) Tel: +44 (0)207 418 8900

James Steel/Oliver Jackson

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISBXGDDLSBBGSD
12345678910
Date   Source Headline
27th Jan 20157:01 amRNSNotice of Results
9th Jan 20154:24 pmRNSBlock Listing Application
8th Jan 201512:00 pmRNSUpdate on Epidiolex Program
8th Jan 201512:00 pmRNSResults in Sativex Phase 3 Cancer Pain Trial
22nd Dec 20147:00 amRNSGW Added to NASDAQ Biotechnology Index
17th Dec 20146:16 pmRNSPublication of UK Annual Report and Accounts
17th Dec 20144:49 pmRNSDirector/PDMR Shareholding
3rd Dec 20148:22 amRNSHolding(s) in Company
2nd Dec 201412:00 pmRNSFinal Results
26th Nov 20147:00 amRNSGW Presents at Piper Jaffray Healthcare Conference
24th Nov 20147:00 amRNSNotice of Results
17th Nov 20143:00 pmRNSPresenting at Jefferies 2014 Healthcare Conference
30th Oct 20147:00 amRNSPhase 2/3 Trial of Epidiolex in Dravet Syndrome
22nd Oct 20147:00 amRNSEpidiolex Orphan Designation from EMA
14th Oct 201412:00 pmRNSResults of Phase 2a Ulcerative Colitis Trial
14th Oct 201412:00 pmRNSNew Physician Reports of Epidiolex Treatment
7th Oct 20149:45 amRNSAdditional Listing
29th Sep 20141:00 pmRNSGW Research and Development Day Details
24th Sep 20147:00 amRNSPresenting at Leerink Rare Disease Roundtable 2014
29th Aug 201412:20 pmRNSDirector/PDMR Shareholding
28th Aug 20147:00 amRNSPresenting at Upcoming Investor Conferences
18th Aug 201411:19 amRNSBlocklisting Interim Review
12th Aug 20144:32 pmRNSGrant of Options
6th Aug 20147:00 amRNSThird Quarter Financial Results
30th Jul 20147:00 amRNSNotice of Results
8th Jul 201410:18 amRNSHolding(s) in Company
30th Jun 20145:15 pmRNSHolding(s) in Company
30th Jun 20145:12 pmRNSHolding(s) in Company
30th Jun 20142:11 pmRNSHolding(s) in Company
25th Jun 20144:16 pmRNSClosing of U.S. Public Offering of ADSs on NASDAQ
24th Jun 20149:18 amRNSExercise of Underwriters' Option to Purchase ADSs
19th Jun 20147:00 amRNSPricing of U.S. Public Offering of ADSs
18th Jun 20147:00 amRNSProposed Public Offering of ADSs
17th Jun 201412:00 pmRNSEpidiolex IND Data
9th Jun 201412:34 pmRNSBlock Listing Application
6th Jun 20147:00 amRNSEpidiolex Fast Track Designation - Dravet Syndrome
29th May 20143:11 pmRNSHolding(s) in Company
8th May 20145:00 pmRNSPresenting at BAML 2014 Health Care Conference
7th May 20147:02 amRNSHalf Yearly Report
7th May 20147:00 amRNSIND for Epidiolex Ph 2/3 Trial in Dravet Syndrome
6th May 20145:54 pmRNSHolding(s) in Company
6th May 20147:01 amRNSAppointment of VP, Clinical Science
29th Apr 20145:30 pmRNSNotice of Results
28th Apr 20141:46 pmRNSHolding(s) in Company
28th Apr 20147:00 amRNSSativex FDA Fast Track Designation in Cancer Pain
19th Mar 20143:24 pmRNSHolding(s) in Company
17th Mar 20147:00 amRNSUpdate on Cannabinoid Pipeline
11th Mar 20142:34 pmRNSAnnual General Meeting
28th Feb 20141:00 pmRNSFDA Orphan Drug Designation received for Epidiolex
27th Feb 20147:00 amRNSGW to Present at Cowen Health Care Conference
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
KCOM
KCOM
LSE
0.00%
GWP
GWP.L
LSE
0.00%
UVEL
UVEL.L
LSE
0.00%
GGP
Greatland Resources
LSE
-2.84%
MRC
Mercantile Investment Trust PLC
LSE
-0.74%
Trending
FORG
Forgent
LSE
0.00%
HEMO
Hemogenyx Pharmaceuticals
LSE
2.76%
BT.A
BT
LSE
0.23%
PREM
Premier African Minerals
LSE
-2.44%
TBN.US
Tamboran Resources Corp.
CBOE
-2.51%